Chapter 48 7348809A Radioactive Drug Research Committee
Detailed guidance document from FDA and regulatory agencies.
Document Details
Program
April 16, 2018
December 1, 2018
bfb941da-2647-409d-bbc4-1bdb2311eaf4
Related Documents
CDER CDRH Combo Product Compliance Program
ProgramJune 4, 2020Center for Biologics Evaluation and Research
CHAPTER 48 - 7348809 Bioresearch Monitoring
ProgramApril 4, 2025Office of Regulatory Affairs
Final In Vivo Bioavailability-Bioequivalence Studies- Analytical
ProgramMay 1, 2018Office of Regulatory Affairs
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.